2019 as well as having the enhancing cost control measures. The details of the Company's performance were as follows: 2018 2019 YoY Mio. % Mio. % Mio. % Rental and Service Income 534.1 58.3% 465.9 50.2
, with 0.18 million baht decrease with no significantly transaction changes. 2. Cost of sale , Profit margin For Quarter 1 of the year 2020, the company had cost of sale of 98.36 million bath compare to
million or 7%, mainly due to an increase in cost of real estate sold which varied with an increase in revenue from sales of real estate. Page 3 of 4 IV Expense (Unit: Million Baht) Second quarter 6-month
) Expense Quarter 2/2020 company and its subsidiaries has total expenses of 607.05 Million Baht as 227.63 Million Baht decreased from same period of year 2019 which has total expenses of 834.68 Million Baht
Floor, Silom Road, Suriyawong, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th 3-Month Period Ending March 31st 2020 2019 Change MB % MB % MB % Cost of Sales 35.76
for the openness of the free trade policy Economic expansion in the developing countries and the continued growth of low-cost airlines, especially in Asia. For the total multi-products fuel
% Million Baht % Selling expenses 22 1% 25 1% (3) (12%) Administrative expenses 191 11% 202 10% (11) (5%) Finance cost 28 2% 32 2% (4) (13%) Income tax expenses 29 2% 30 2% (1) (3%) Selling expenses Selling
. Other operating expenses fell Baht 471 million or 2.83 percent over-quarter. Given that the decrease in income was more pronounced than that of other operating expenses, our cost to income ratio rose to
, the growth in expenses was less pronounced than that of net total income. As a result, our cost to income ratio decreased to 41.07 percent compared to the previous quarter, which was still better than